Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China flag China · Delayed Price · Currency is CNY
6.14
+0.22 (3.72%)
Sep 1, 2026, 3:04 PM CST

SHE:300639 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
654.72669.64815.531,1045,5972,673
Revenue Growth
-9.27%-17.89%-26.16%-80.27%109.39%97.34%
Gross Profit
287.99292.28375.18662.353,7901,808
Operating Income
-52.68-188.4-810.23-5.622,4241,046
Net Income
-10.09-130.94-654.88140.471,726852.16
Earnings Per Share
-0.02-0.21-1.02-2.621.29
EPS Growth
----102.58%118.80%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
in Vitro Diagnostic Reagents, Supporting Instruments and Consumables
549.6
Medical Testing Services
267.26
Medical Services
27.49
Offset of Business Segment
-174.71
Total
669.64

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
881.711,039963.271,0721,4121,199
Total Debt
83.0689.5687.5156.65139.49185.15
Net Cash (Debt)
798.65949.15875.761,0151,2721,014
Net Cash Growth
-0.90%8.38%-13.75%-20.20%25.48%-13.74%
Net Cash Per Share
1.261.521.36-1.931.54

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
356.92341.6178.78319.61,309631.34
Capital Expenditures
-150.9-92.39-148.33-385.32-734.37-641.07
Free Cash Flow
206.02249.21-69.55-65.72574.85-9.73
Free Cash Flow Growth
127.90%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
43.99%43.65%46.01%59.97%67.72%67.62%
Operating Margin
-8.05%-28.13%-99.35%-0.51%43.30%39.13%
Pretax Margin
-0.27%-25.29%-102.14%3.33%38.02%39.55%
Profit Margin
-1.54%-19.55%-80.30%12.72%30.84%31.88%
FCF Margin
31.47%37.22%-8.53%-5.95%10.27%-0.36%

Dividends

Fiscal YearFY 2023FY 2022FY 2021
Period EndingDec '23 Jan '23 Jan '22
Dividend Per Share
0.0650.2330.155
Dividend Per Share Growth
-72.14%50.03%74.13%
Dividend Yield
0.70%2.15%1.24%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
---42.644.2610.09
Forward PE
-18.8924.2023.954.8812.96
P/FCF Ratio
18.0313.55--12.81-
PS Ratio
5.685.044.635.421.323.22